title: Acute blood pressure elevations with caffeine in men with borderline systemic hypertension.
abstract: Whether the vasoconstrictive actions of caffeine are enhanced in hypertensive persons has not been demonstrated. Thus, caffeine (3.3 mg/kg) versus placebo was tested in 48 healthy men (aged 20 to 35 years) selected after screening on 2 separate occasions. Borderline hypertensive men (n = 24) were selected with screening systolic blood pressure (BP) of 140 to 160 mm Hg and/or diastolic BP 90 to 99 mm Hg. Low-risk controls (n = 24) reported no parental history of hypertension and had screening BP < 130/85 mm Hg. Participants were then tested on 2 occasions after 12-hour abstinence from caffeine in each of 2 protocols; this required a total of 4 laboratory visits. Caffeine-induced changes in diastolic BP were 2 to 3 times larger in borderline subjects than in controls (+8.4 vs +3.8 mm Hg, p < 0.0001), and were attributable to larger changes in impedance-derived measures of systemic vascular resistance (+135 vs +45 dynes.s.cm-5, p < 0.004). These findings were consistent and reached significance in both protocols. The percentage of borderline subjects in whom diastolic BP changes exceeded the median control response was 96%. Consequently, whereas all participants exhibited normotensive levels during the resting predrug baseline, 33% of borderline subjects achieved hypertensive BP levels after caffeine ingestion. Thus, in borderline hypertensive men, exaggerated responses to caffeine were: selective for diastolic BP, consistent with greater vasoconstriction, replicated in 2 protocols, and representative of nearly all borderline hypertensives. We suspect that the potential for caffeine to stabilize high resistance states in susceptible persons suggests that its use may facilitate their disease progression, as well as hinder accurate diagnosis and treatment.
authors.affiliation: Veterans Affairs Medical Center, Medical Research Service & the Behavioral Sciences Laboratories, Oklahoma City 73104, USA.
authors.forename: G A
authors.initials: GA
authors.lastname: Pincomb
authors.forename: W R
authors.initials: WR
authors.lastname: Lovallo
authors.forename: B S
authors.initials: BS
authors.lastname: McKey
authors.forename: B H
authors.initials: BH
authors.lastname: Sung
authors.forename: R B
authors.initials: RB
authors.lastname: Passey
authors.forename: S A
authors.initials: SA
authors.lastname: Everson
authors.forename: M F
authors.initials: MF
authors.lastname: Wilson
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D001794:Blood Pressure / Q000187:drug effects*; D002110:Caffeine / Q000009:adverse effects*; D003971:Diastole; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D008297:Male; D013268:Stimulation, Chemical; D014655:Vascular Resistance / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects
chemical_list: D002110:Caffeine